SMS Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SMSPHARMA BSE: 532815

₹476.60

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #62 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
SMS Pharmaceuticals Limited (this stock)	4,463	47.9	13.0%	84.8%	—	64	3	88

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹4,783 Cr

EV / EBITDA

26.1x

EV / Sales

5.33x

Market cap / Sales

4.97x

Earnings yield

2.09%

Quarterly Financials

Download CSV

Standalone Consolidated

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	207	28	21	₹2.2600
March 31, 2026	238	27	21	₹2.2900
Dec. 31, 2025	210	31	23	₹2.5700
Sept. 30, 2025	242	34	25	₹2.8200
June 30, 2025	196	24	18	₹
March 31, 2025	248	29	21	₹2.4300
Dec. 31, 2024	173	23	17	₹2.0300
Sept. 30, 2024	197	20	14	₹1.6800
June 30, 2024	164	22	16	₹1.9300
March 31, 2024	246	22	16	₹1.8800
Dec. 31, 2023	161	16	12	₹1.4400
Sept. 30, 2023	167	15	12	₹1.4200
June 30, 2023	135	13	9	₹1.1000

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	209	241	214	244	250	175	198	166	247	163	167	136	151
Operating revenue	207	238	210	242	248	173	197	164	246	161	167	135	149
Other income	2	3	4	1	1	2	1	1	2	1	1	1	1
Operating expenses	165	198	167	194	207	140	165	131	212	133	139	109	126
Operating profit	42	40	44	48	41	33	32	33	33	29	28	27	23
Operating profit margin	20.2%	16.8%	20.8%	20.0%	16.7%	19.2%	16.2%	20.3%	13.6%	17.9%	16.7%	19.7%	15.6%
Depreciation	10	10	10	10	9	9	9	8	8	8	8	8	8
Interest	5	5	6	6	5	4	5	5	6	6	6	6	6
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	28	27	31	34	29	23	20	22	22	16	15	13	11
Tax	7	6	8	9	8	5	6	5	6	4	3	4	3
Net profit	—	21	23	25	21	17	14	16	16	12	12	9	8
EPS	2.26	2.29	2.57	2.82	2.43	2.03	1.68	1.93	1.88	1.44	1.42	1.10	0.95
Net profit (TTM)	—	90	86	77	68	64	59	56	49	42	34	23	4
EPS (TTM)	9.94	10.11	9.85	8.96	8.07	7.52	6.93	6.67	5.84	4.91	4.06	2.73	0.47

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	887	116	88
March 31, 2025	783	93	68
March 31, 2024	709	66	49
March 31, 2023	522	6	4

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	—	—	—	789^†	714^†	527^†	525^†	567^†	417^†	468^†	468^†	600^†
Operating revenue	19.3%	9.5%	887	783	709	522	520^†	563^†	412^†	465^†	465^†	598^†
Other income	—	—	—	6^†	4^†	5^†	5^†	4^†	5^†	3^†	3^†	2^†
Operating expenses	—	—	—	643^†	592^†	467^†	405^†	443^†	332^†	375^†	372^†	484^†
Operating profit	—	—	—	140^†	117^†	55^†	114^†	121^†	80^†	90^†	93^†	114^†
Operating profit margin	—	—	—	17.9%^†	16.5%^†	10.5%^†	22.0%^†	21.4%^†	19.4%^†	19.4%^†	20.0%^†	19.1%^†
Depreciation	—	—	—	34^†	32^†	32^†	32^†	22^†	22^†	19^†	20^†	23^†
Interest	—	—	—	19^†	23^†	22^†	19^†	11^†	12^†	12^†	15^†	20^†
Exceptional items, gain / (loss)	—	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	175.7%	5.0%	116	93	66	6	69^†	91^†	51^†	62^†	60^†	57^†
Tax	—	—	—	25^†	17^†	1^†	1^†	30^†	18^†	21^†	20^†	9^†
Net profit	177.8%	7.5%	88	68	49	4	68^†	61^†	33^†	41^†	40^†	48^†
EPS	—	—	—	8.07^†	5.84^†	0.47^†	8.04^†	7.20^†	3.88^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	—	17.9%^†	16.5%^†	10.5%^†	22.0%^†	21.4%^†	19.4%^†	19.4%^†	20.0%^†	19.1%^†
EBIT margin	—	14.3%^†	12.7%^†	5.3%^†	16.8%^†	18.2%^†	15.3%^†	16.0%^†	16.3%^†	12.8%^†
PBT margin	13.1%	11.9%	9.4%	1.1%	13.2%^†	16.2%^†	12.4%^†	13.4%^†	13.0%^†	9.5%^†
Net margin	9.9%	8.7%	7.0%	0.8%	13.1%^†	10.8%^†	8.0%^†	8.9%^†	8.7%^†	8.0%^†
Interest coverage	—	6.03x^†	3.83x^†	1.25x^†	4.64x^†	9.16x^†	5.17x^†	6.25x^†	4.90x^†	3.88x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.81x	1.71x	—	—	—	—	—	—	—	—
Quick ratio	0.81x	0.83x	—	—	—	—	—	—	—	—
Debt to equity	0.45x	0.46x	—	—	—	—	—	—	—	—
Return on equity	10.9%	10.2%	—	—	—	—	—	—	—	—
Return on assets	6.3%	5.8%	—	—	—	—	—	—	—	—
Return on capital employed	—	13.0%^†	—	—	—	—	—	—	—	—
Asset turnover	0.64x	0.66x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	61	-132	76	125	-64
March 31, 2025	82	-123	47	123	-42
March 31, 2024	50	-52	31	52	-2
March 31, 2023	22	-30	-32	30	-7
March 31, 2022	40	-27	-7	27	13

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	1,381	805	795	193	172	637	353	46	531	351
March 31, 2025	1,186	673	664	171	139	554	324	41	531	285
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.